Delivery Order SPE2DB22D3016-SPE2DB25FBEF5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $5,418.73. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitive award with no set-aside designation. The order will be performed at the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $2,551.95 under a firm fixed-price contract type. This non-set-aside award represents a routine pharmaceutical delivery fulfilling federal medical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $18,635.53. This firm fixed-price delivery order, which is due for completion by September 3, 2025, represents a standalone procurement from the company's significant presence in federal pharmaceutical distribution. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, carrying a ceiling value of $1,134.20 and an ultimate completion date of August 18, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $10,311.22. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is set to be completed by August 8, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lidocaine 5% Patch 30S with a ceiling value of $10,877.33. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 11, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lidocaine 5% Patch 30s at a ceiling value of $6,861.83. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order is scheduled for completion by August 14, 2025,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price delivery order, valued at $16,405.94, represents a non-competitive award with an ultimate completion date of August 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,722.08 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lidocaine 5% Patch 30s, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $2,722.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s on September 10, 2025, with an ultimate completion date of September 11, 2025. This contract represents a non-set-aside competitive award for pharmaceutical supplies to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for military and...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEF5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $25,597.45. This is a firm fixed-price, competitively awarded contract with no set-aside designation, and performance will be completed by August 7, 2025, at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle extending through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company has demonstrated extensive capability in fulfilling federal medical supply needs through competitive procurement, with a diverse portfolio spanning brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA's current strategic planning includes establishing the Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among key providers supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.6k | 8/6/25 |